nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2E1—Fingolimod—multiple sclerosis	0.1	0.135	CbGbCtD
Azelastine—CYP2A6—Prednisolone—multiple sclerosis	0.0627	0.0847	CbGbCtD
Azelastine—CYP2D6—Fingolimod—multiple sclerosis	0.0477	0.0645	CbGbCtD
Azelastine—CYP2E1—Mitoxantrone—multiple sclerosis	0.047	0.0636	CbGbCtD
Azelastine—CYP2A6—Dexamethasone—multiple sclerosis	0.0369	0.05	CbGbCtD
Azelastine—ABCB1—Methylprednisolone—multiple sclerosis	0.0326	0.0441	CbGbCtD
Azelastine—CYP1A1—Dexamethasone—multiple sclerosis	0.0316	0.0427	CbGbCtD
Azelastine—CYP3A4—Fingolimod—multiple sclerosis	0.0303	0.041	CbGbCtD
Azelastine—CYP2C19—Prednisone—multiple sclerosis	0.0245	0.0331	CbGbCtD
Azelastine—CYP2E1—Dexamethasone—multiple sclerosis	0.0244	0.033	CbGbCtD
Azelastine—CYP2B6—Dexamethasone—multiple sclerosis	0.024	0.0325	CbGbCtD
Azelastine—ABCB1—Mitoxantrone—multiple sclerosis	0.0238	0.0322	CbGbCtD
Azelastine—ABCB1—Betamethasone—multiple sclerosis	0.0212	0.0287	CbGbCtD
Azelastine—ABCB1—Prednisolone—multiple sclerosis	0.0209	0.0283	CbGbCtD
Azelastine—ABCB1—Prednisone—multiple sclerosis	0.0197	0.0267	CbGbCtD
Azelastine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0195	0.0264	CbGbCtD
Azelastine—CYP3A5—Dexamethasone—multiple sclerosis	0.0189	0.0256	CbGbCtD
Azelastine—CYP2C8—Dexamethasone—multiple sclerosis	0.0182	0.0246	CbGbCtD
Azelastine—CYP2C19—Dexamethasone—multiple sclerosis	0.0153	0.0207	CbGbCtD
Azelastine—CYP3A4—Triamcinolone—multiple sclerosis	0.0148	0.02	CbGbCtD
Azelastine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0142	0.0193	CbGbCtD
Azelastine—CYP2C9—Dexamethasone—multiple sclerosis	0.0127	0.0172	CbGbCtD
Azelastine—CYP3A4—Betamethasone—multiple sclerosis	0.0127	0.0172	CbGbCtD
Azelastine—CYP3A4—Prednisolone—multiple sclerosis	0.0125	0.0169	CbGbCtD
Azelastine—ABCB1—Dexamethasone—multiple sclerosis	0.0123	0.0167	CbGbCtD
Azelastine—CYP3A4—Prednisone—multiple sclerosis	0.0118	0.016	CbGbCtD
Azelastine—CYP2D6—Dexamethasone—multiple sclerosis	0.0116	0.0157	CbGbCtD
Azelastine—ABCB1—Methotrexate—multiple sclerosis	0.00991	0.0134	CbGbCtD
Azelastine—CYP3A4—Dexamethasone—multiple sclerosis	0.00739	0.00999	CbGbCtD
Azelastine—Anxiety—Mitoxantrone—multiple sclerosis	0.000344	0.00209	CcSEcCtD
Azelastine—Discomfort—Mitoxantrone—multiple sclerosis	0.000341	0.00207	CcSEcCtD
Azelastine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000338	0.00205	CcSEcCtD
Azelastine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000337	0.00205	CcSEcCtD
Azelastine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000335	0.00203	CcSEcCtD
Azelastine—Confusional state—Mitoxantrone—multiple sclerosis	0.000334	0.00203	CcSEcCtD
Azelastine—Dizziness—Cladribine—multiple sclerosis	0.000333	0.00202	CcSEcCtD
Azelastine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000331	0.00201	CcSEcCtD
Azelastine—Infection—Mitoxantrone—multiple sclerosis	0.000329	0.002	CcSEcCtD
Azelastine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000328	0.00199	CcSEcCtD
Azelastine—Abdominal pain—Azathioprine—multiple sclerosis	0.000324	0.00197	CcSEcCtD
Azelastine—Body temperature increased—Azathioprine—multiple sclerosis	0.000324	0.00197	CcSEcCtD
Azelastine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000323	0.00196	CcSEcCtD
Azelastine—Vomiting—Cladribine—multiple sclerosis	0.00032	0.00194	CcSEcCtD
Azelastine—Rash—Cladribine—multiple sclerosis	0.000318	0.00193	CcSEcCtD
Azelastine—Dermatitis—Cladribine—multiple sclerosis	0.000317	0.00193	CcSEcCtD
Azelastine—Weight increased—Prednisone—multiple sclerosis	0.000316	0.00192	CcSEcCtD
Azelastine—Headache—Cladribine—multiple sclerosis	0.000315	0.00192	CcSEcCtD
Azelastine—Vision blurred—Prednisolone—multiple sclerosis	0.000314	0.0019	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000309	0.00187	CcSEcCtD
Azelastine—Visual impairment—Betamethasone—multiple sclerosis	0.000307	0.00187	CcSEcCtD
Azelastine—Visual impairment—Dexamethasone—multiple sclerosis	0.000307	0.00187	CcSEcCtD
Azelastine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000302	0.00183	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000302	0.00183	CcSEcCtD
Azelastine—Malaise—Prednisolone—multiple sclerosis	0.0003	0.00182	CcSEcCtD
Azelastine—Dysgeusia—Triamcinolone—multiple sclerosis	0.0003	0.00182	CcSEcCtD
Azelastine—Nausea—Cladribine—multiple sclerosis	0.000299	0.00182	CcSEcCtD
Azelastine—Vertigo—Prednisolone—multiple sclerosis	0.000299	0.00182	CcSEcCtD
Azelastine—Eye disorder—Dexamethasone—multiple sclerosis	0.000298	0.00181	CcSEcCtD
Azelastine—Eye disorder—Betamethasone—multiple sclerosis	0.000298	0.00181	CcSEcCtD
Azelastine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000297	0.0018	CcSEcCtD
Azelastine—Back pain—Triamcinolone—multiple sclerosis	0.000296	0.0018	CcSEcCtD
Azelastine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000295	0.00179	CcSEcCtD
Azelastine—Somnolence—Mitoxantrone—multiple sclerosis	0.000294	0.00179	CcSEcCtD
Azelastine—Asthma—Methotrexate—multiple sclerosis	0.00029	0.00176	CcSEcCtD
Azelastine—Hypertension—Prednisolone—multiple sclerosis	0.000287	0.00174	CcSEcCtD
Azelastine—Fatigue—Mitoxantrone—multiple sclerosis	0.000285	0.00173	CcSEcCtD
Azelastine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000284	0.00172	CcSEcCtD
Azelastine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000283	0.00172	CcSEcCtD
Azelastine—Pain—Mitoxantrone—multiple sclerosis	0.000283	0.00172	CcSEcCtD
Azelastine—Constipation—Mitoxantrone—multiple sclerosis	0.000283	0.00172	CcSEcCtD
Azelastine—Diarrhoea—Azathioprine—multiple sclerosis	0.00028	0.0017	CcSEcCtD
Azelastine—Discomfort—Prednisolone—multiple sclerosis	0.00028	0.0017	CcSEcCtD
Azelastine—Malaise—Triamcinolone—multiple sclerosis	0.000276	0.00168	CcSEcCtD
Azelastine—Malaise—Methylprednisolone—multiple sclerosis	0.000275	0.00167	CcSEcCtD
Azelastine—Vertigo—Triamcinolone—multiple sclerosis	0.000275	0.00167	CcSEcCtD
Azelastine—Vertigo—Methylprednisolone—multiple sclerosis	0.000274	0.00167	CcSEcCtD
Azelastine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000273	0.00166	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000272	0.00165	CcSEcCtD
Azelastine—Dizziness—Azathioprine—multiple sclerosis	0.000271	0.00164	CcSEcCtD
Azelastine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000271	0.00164	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00027	0.00164	CcSEcCtD
Azelastine—Cough—Triamcinolone—multiple sclerosis	0.000267	0.00162	CcSEcCtD
Azelastine—Tachycardia—Prednisolone—multiple sclerosis	0.000265	0.00161	CcSEcCtD
Azelastine—Hypertension—Triamcinolone—multiple sclerosis	0.000264	0.0016	CcSEcCtD
Azelastine—Hypertension—Methylprednisolone—multiple sclerosis	0.000264	0.0016	CcSEcCtD
Azelastine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000262	0.00159	CcSEcCtD
Azelastine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000262	0.00159	CcSEcCtD
Azelastine—Myalgia—Triamcinolone—multiple sclerosis	0.000261	0.00158	CcSEcCtD
Azelastine—Vomiting—Azathioprine—multiple sclerosis	0.00026	0.00158	CcSEcCtD
Azelastine—Myalgia—Methylprednisolone—multiple sclerosis	0.00026	0.00158	CcSEcCtD
Azelastine—Eye disorder—Prednisone—multiple sclerosis	0.00026	0.00158	CcSEcCtD
Azelastine—Anxiety—Methylprednisolone—multiple sclerosis	0.000259	0.00157	CcSEcCtD
Azelastine—Rash—Azathioprine—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Azelastine—Dermatitis—Azathioprine—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Azelastine—Flushing—Prednisone—multiple sclerosis	0.000258	0.00157	CcSEcCtD
Azelastine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000258	0.00156	CcSEcCtD
Azelastine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000258	0.00156	CcSEcCtD
Azelastine—Discomfort—Triamcinolone—multiple sclerosis	0.000257	0.00156	CcSEcCtD
Azelastine—Discomfort—Methylprednisolone—multiple sclerosis	0.000257	0.00156	CcSEcCtD
Azelastine—Headache—Azathioprine—multiple sclerosis	0.000257	0.00156	CcSEcCtD
Azelastine—Dry mouth—Triamcinolone—multiple sclerosis	0.000255	0.00155	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000251	0.00153	CcSEcCtD
Azelastine—Confusional state—Methylprednisolone—multiple sclerosis	0.000251	0.00153	CcSEcCtD
Azelastine—Malaise—Betamethasone—multiple sclerosis	0.00025	0.00152	CcSEcCtD
Azelastine—Malaise—Dexamethasone—multiple sclerosis	0.00025	0.00152	CcSEcCtD
Azelastine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00025	0.00152	CcSEcCtD
Azelastine—Vertigo—Dexamethasone—multiple sclerosis	0.000249	0.00151	CcSEcCtD
Azelastine—Vertigo—Betamethasone—multiple sclerosis	0.000249	0.00151	CcSEcCtD
Azelastine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000249	0.00151	CcSEcCtD
Azelastine—Infection—Triamcinolone—multiple sclerosis	0.000248	0.00151	CcSEcCtD
Azelastine—Infection—Methylprednisolone—multiple sclerosis	0.000248	0.0015	CcSEcCtD
Azelastine—Haematuria—Methotrexate—multiple sclerosis	0.000247	0.0015	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—multiple sclerosis	0.000244	0.00148	CcSEcCtD
Azelastine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000244	0.00148	CcSEcCtD
Azelastine—Paraesthesia—Prednisolone—multiple sclerosis	0.000244	0.00148	CcSEcCtD
Azelastine—Tachycardia—Triamcinolone—multiple sclerosis	0.000244	0.00148	CcSEcCtD
Azelastine—Nausea—Azathioprine—multiple sclerosis	0.000243	0.00148	CcSEcCtD
Azelastine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000243	0.00148	CcSEcCtD
Azelastine—Hypertension—Dexamethasone—multiple sclerosis	0.00024	0.00146	CcSEcCtD
Azelastine—Hypertension—Betamethasone—multiple sclerosis	0.00024	0.00146	CcSEcCtD
Azelastine—Asthenia—Mitoxantrone—multiple sclerosis	0.000237	0.00144	CcSEcCtD
Azelastine—Myalgia—Betamethasone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Azelastine—Myalgia—Dexamethasone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Azelastine—Anxiety—Dexamethasone—multiple sclerosis	0.000236	0.00143	CcSEcCtD
Azelastine—Anxiety—Betamethasone—multiple sclerosis	0.000236	0.00143	CcSEcCtD
Azelastine—Discomfort—Betamethasone—multiple sclerosis	0.000234	0.00142	CcSEcCtD
Azelastine—Discomfort—Dexamethasone—multiple sclerosis	0.000234	0.00142	CcSEcCtD
Azelastine—Pain—Prednisolone—multiple sclerosis	0.000232	0.00141	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—multiple sclerosis	0.00023	0.0014	CcSEcCtD
Azelastine—Vision blurred—Prednisone—multiple sclerosis	0.000228	0.00138	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000228	0.00138	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000227	0.00138	CcSEcCtD
Azelastine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000227	0.00138	CcSEcCtD
Azelastine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000227	0.00138	CcSEcCtD
Azelastine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000226	0.00138	CcSEcCtD
Azelastine—Infection—Betamethasone—multiple sclerosis	0.000225	0.00137	CcSEcCtD
Azelastine—Infection—Dexamethasone—multiple sclerosis	0.000225	0.00137	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000224	0.00136	CcSEcCtD
Azelastine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000224	0.00136	CcSEcCtD
Azelastine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000224	0.00136	CcSEcCtD
Azelastine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000224	0.00136	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—multiple sclerosis	0.000224	0.00136	CcSEcCtD
Azelastine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000223	0.00135	CcSEcCtD
Azelastine—Agitation—Prednisone—multiple sclerosis	0.000222	0.00135	CcSEcCtD
Azelastine—Tachycardia—Betamethasone—multiple sclerosis	0.000221	0.00134	CcSEcCtD
Azelastine—Tachycardia—Dexamethasone—multiple sclerosis	0.000221	0.00134	CcSEcCtD
Azelastine—Malaise—Prednisone—multiple sclerosis	0.000218	0.00132	CcSEcCtD
Azelastine—Vertigo—Prednisone—multiple sclerosis	0.000217	0.00132	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—multiple sclerosis	0.000217	0.00132	CcSEcCtD
Azelastine—Fatigue—Triamcinolone—multiple sclerosis	0.000215	0.00131	CcSEcCtD
Azelastine—Fatigue—Methylprednisolone—multiple sclerosis	0.000215	0.0013	CcSEcCtD
Azelastine—Pain—Triamcinolone—multiple sclerosis	0.000214	0.0013	CcSEcCtD
Azelastine—Vomiting—Mitoxantrone—multiple sclerosis	0.00021	0.00128	CcSEcCtD
Azelastine—Hypertension—Prednisone—multiple sclerosis	0.000209	0.00127	CcSEcCtD
Azelastine—Rash—Mitoxantrone—multiple sclerosis	0.000209	0.00127	CcSEcCtD
Azelastine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000209	0.00127	CcSEcCtD
Azelastine—Headache—Mitoxantrone—multiple sclerosis	0.000207	0.00126	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000206	0.00125	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000206	0.00125	CcSEcCtD
Azelastine—Myalgia—Prednisone—multiple sclerosis	0.000206	0.00125	CcSEcCtD
Azelastine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000206	0.00125	CcSEcCtD
Azelastine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000205	0.00125	CcSEcCtD
Azelastine—Anxiety—Prednisone—multiple sclerosis	0.000205	0.00125	CcSEcCtD
Azelastine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000204	0.00124	CcSEcCtD
Azelastine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000203	0.00124	CcSEcCtD
Azelastine—Paraesthesia—Betamethasone—multiple sclerosis	0.000203	0.00124	CcSEcCtD
Azelastine—Discomfort—Prednisone—multiple sclerosis	0.000203	0.00124	CcSEcCtD
Azelastine—Hypersensitivity—Prednisolone—multiple sclerosis	0.0002	0.00121	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—multiple sclerosis	0.000198	0.0012	CcSEcCtD
Azelastine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Azelastine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Azelastine—Nausea—Mitoxantrone—multiple sclerosis	0.000197	0.00119	CcSEcCtD
Azelastine—Infection—Prednisone—multiple sclerosis	0.000196	0.00119	CcSEcCtD
Azelastine—Back pain—Methotrexate—multiple sclerosis	0.000195	0.00119	CcSEcCtD
Azelastine—Fatigue—Dexamethasone—multiple sclerosis	0.000195	0.00119	CcSEcCtD
Azelastine—Fatigue—Betamethasone—multiple sclerosis	0.000195	0.00119	CcSEcCtD
Azelastine—Pain—Dexamethasone—multiple sclerosis	0.000194	0.00118	CcSEcCtD
Azelastine—Pain—Betamethasone—multiple sclerosis	0.000194	0.00118	CcSEcCtD
Azelastine—Tachycardia—Prednisone—multiple sclerosis	0.000193	0.00117	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—multiple sclerosis	0.00019	0.00116	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Azelastine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000187	0.00113	CcSEcCtD
Azelastine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000187	0.00113	CcSEcCtD
Azelastine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000185	0.00113	CcSEcCtD
Azelastine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000185	0.00113	CcSEcCtD
Azelastine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000184	0.00112	CcSEcCtD
Azelastine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000184	0.00111	CcSEcCtD
Azelastine—Malaise—Methotrexate—multiple sclerosis	0.000182	0.00111	CcSEcCtD
Azelastine—Vertigo—Methotrexate—multiple sclerosis	0.000182	0.0011	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00018	0.00109	CcSEcCtD
Azelastine—Dizziness—Prednisolone—multiple sclerosis	0.00018	0.00109	CcSEcCtD
Azelastine—Asthenia—Triamcinolone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Abdominal pain—Betamethasone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Body temperature increased—Betamethasone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Asthenia—Methylprednisolone—multiple sclerosis	0.000179	0.00109	CcSEcCtD
Azelastine—Paraesthesia—Prednisone—multiple sclerosis	0.000177	0.00108	CcSEcCtD
Azelastine—Pruritus—Triamcinolone—multiple sclerosis	0.000177	0.00107	CcSEcCtD
Azelastine—Cough—Methotrexate—multiple sclerosis	0.000176	0.00107	CcSEcCtD
Azelastine—Pruritus—Methylprednisolone—multiple sclerosis	0.000176	0.00107	CcSEcCtD
Azelastine—Chest pain—Methotrexate—multiple sclerosis	0.000172	0.00104	CcSEcCtD
Azelastine—Myalgia—Methotrexate—multiple sclerosis	0.000172	0.00104	CcSEcCtD
Azelastine—Rash—Prednisolone—multiple sclerosis	0.000171	0.00104	CcSEcCtD
Azelastine—Dermatitis—Prednisolone—multiple sclerosis	0.000171	0.00104	CcSEcCtD
Azelastine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00017	0.00104	CcSEcCtD
Azelastine—Fatigue—Prednisone—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Azelastine—Headache—Prednisolone—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Azelastine—Discomfort—Methotrexate—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Azelastine—Constipation—Prednisone—multiple sclerosis	0.000169	0.00102	CcSEcCtD
Azelastine—Confusional state—Methotrexate—multiple sclerosis	0.000166	0.00101	CcSEcCtD
Azelastine—Dizziness—Triamcinolone—multiple sclerosis	0.000165	0.001	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000165	0.001	CcSEcCtD
Azelastine—Dizziness—Methylprednisolone—multiple sclerosis	0.000165	0.001	CcSEcCtD
Azelastine—Infection—Methotrexate—multiple sclerosis	0.000164	0.000995	CcSEcCtD
Azelastine—Feeling abnormal—Prednisone—multiple sclerosis	0.000163	0.000987	CcSEcCtD
Azelastine—Asthenia—Betamethasone—multiple sclerosis	0.000163	0.000987	CcSEcCtD
Azelastine—Asthenia—Dexamethasone—multiple sclerosis	0.000163	0.000987	CcSEcCtD
Azelastine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000161	0.00098	CcSEcCtD
Azelastine—Nausea—Prednisolone—multiple sclerosis	0.000161	0.00098	CcSEcCtD
Azelastine—Pruritus—Dexamethasone—multiple sclerosis	0.00016	0.000974	CcSEcCtD
Azelastine—Pruritus—Betamethasone—multiple sclerosis	0.00016	0.000974	CcSEcCtD
Azelastine—Vomiting—Triamcinolone—multiple sclerosis	0.000159	0.000964	CcSEcCtD
Azelastine—Vomiting—Methylprednisolone—multiple sclerosis	0.000158	0.000962	CcSEcCtD
Azelastine—Rash—Triamcinolone—multiple sclerosis	0.000157	0.000956	CcSEcCtD
Azelastine—Dermatitis—Triamcinolone—multiple sclerosis	0.000157	0.000955	CcSEcCtD
Azelastine—Rash—Methylprednisolone—multiple sclerosis	0.000157	0.000954	CcSEcCtD
Azelastine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000157	0.000953	CcSEcCtD
Azelastine—Headache—Triamcinolone—multiple sclerosis	0.000156	0.00095	CcSEcCtD
Azelastine—HRH3—brainstem—multiple sclerosis	0.000156	0.119	CbGeAlD
Azelastine—Headache—Methylprednisolone—multiple sclerosis	0.000156	0.000948	CcSEcCtD
Azelastine—Abdominal pain—Prednisone—multiple sclerosis	0.000156	0.000947	CcSEcCtD
Azelastine—Body temperature increased—Prednisone—multiple sclerosis	0.000156	0.000947	CcSEcCtD
Azelastine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000155	0.000941	CcSEcCtD
Azelastine—Diarrhoea—Betamethasone—multiple sclerosis	0.000155	0.000941	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00015	0.000912	CcSEcCtD
Azelastine—Dizziness—Betamethasone—multiple sclerosis	0.00015	0.00091	CcSEcCtD
Azelastine—Dizziness—Dexamethasone—multiple sclerosis	0.00015	0.00091	CcSEcCtD
Azelastine—Nausea—Triamcinolone—multiple sclerosis	0.000148	0.000901	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—multiple sclerosis	0.000148	0.000899	CcSEcCtD
Azelastine—Nausea—Methylprednisolone—multiple sclerosis	0.000148	0.000899	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—multiple sclerosis	0.000147	0.000893	CcSEcCtD
Azelastine—Somnolence—Methotrexate—multiple sclerosis	0.000147	0.00089	CcSEcCtD
Azelastine—Hypersensitivity—Prednisone—multiple sclerosis	0.000145	0.000883	CcSEcCtD
Azelastine—Vomiting—Dexamethasone—multiple sclerosis	0.000144	0.000875	CcSEcCtD
Azelastine—Vomiting—Betamethasone—multiple sclerosis	0.000144	0.000875	CcSEcCtD
Azelastine—Rash—Betamethasone—multiple sclerosis	0.000143	0.000868	CcSEcCtD
Azelastine—Rash—Dexamethasone—multiple sclerosis	0.000143	0.000868	CcSEcCtD
Azelastine—Dermatitis—Betamethasone—multiple sclerosis	0.000143	0.000867	CcSEcCtD
Azelastine—Dermatitis—Dexamethasone—multiple sclerosis	0.000143	0.000867	CcSEcCtD
Azelastine—Fatigue—Methotrexate—multiple sclerosis	0.000142	0.000863	CcSEcCtD
Azelastine—Headache—Betamethasone—multiple sclerosis	0.000142	0.000862	CcSEcCtD
Azelastine—Headache—Dexamethasone—multiple sclerosis	0.000142	0.000862	CcSEcCtD
Azelastine—Asthenia—Prednisone—multiple sclerosis	0.000142	0.00086	CcSEcCtD
Azelastine—Pain—Methotrexate—multiple sclerosis	0.000141	0.000856	CcSEcCtD
Azelastine—Pruritus—Prednisone—multiple sclerosis	0.00014	0.000848	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000136	0.000825	CcSEcCtD
Azelastine—Diarrhoea—Prednisone—multiple sclerosis	0.000135	0.00082	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000135	0.000819	CcSEcCtD
Azelastine—Nausea—Betamethasone—multiple sclerosis	0.000135	0.000817	CcSEcCtD
Azelastine—Nausea—Dexamethasone—multiple sclerosis	0.000135	0.000817	CcSEcCtD
Azelastine—Dizziness—Prednisone—multiple sclerosis	0.00013	0.000792	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—multiple sclerosis	0.00013	0.000792	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—multiple sclerosis	0.00013	0.000792	CcSEcCtD
Azelastine—Vomiting—Prednisone—multiple sclerosis	0.000125	0.000762	CcSEcCtD
Azelastine—Rash—Prednisone—multiple sclerosis	0.000124	0.000756	CcSEcCtD
Azelastine—Dermatitis—Prednisone—multiple sclerosis	0.000124	0.000755	CcSEcCtD
Azelastine—Headache—Prednisone—multiple sclerosis	0.000124	0.000751	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000122	0.000738	CcSEcCtD
Azelastine—Asthenia—Methotrexate—multiple sclerosis	0.000118	0.000719	CcSEcCtD
Azelastine—Nausea—Prednisone—multiple sclerosis	0.000117	0.000712	CcSEcCtD
Azelastine—Pruritus—Methotrexate—multiple sclerosis	0.000117	0.000709	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—multiple sclerosis	0.000113	0.000685	CcSEcCtD
Azelastine—Dizziness—Methotrexate—multiple sclerosis	0.000109	0.000662	CcSEcCtD
Azelastine—Vomiting—Methotrexate—multiple sclerosis	0.000105	0.000637	CcSEcCtD
Azelastine—Rash—Methotrexate—multiple sclerosis	0.000104	0.000631	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—multiple sclerosis	0.000104	0.000631	CcSEcCtD
Azelastine—Headache—Methotrexate—multiple sclerosis	0.000103	0.000627	CcSEcCtD
Azelastine—Nausea—Methotrexate—multiple sclerosis	9.8e-05	0.000595	CcSEcCtD
Azelastine—HRH3—nervous system—multiple sclerosis	8.18e-05	0.0625	CbGeAlD
Azelastine—HRH3—central nervous system—multiple sclerosis	7.88e-05	0.0602	CbGeAlD
Azelastine—HRH3—cerebellum—multiple sclerosis	7.7e-05	0.0588	CbGeAlD
Azelastine—HRH3—brain—multiple sclerosis	6.26e-05	0.0478	CbGeAlD
Azelastine—ADRA1B—nervous system—multiple sclerosis	4.36e-05	0.0333	CbGeAlD
Azelastine—ADRA1B—central nervous system—multiple sclerosis	4.2e-05	0.032	CbGeAlD
Azelastine—CYP2A6—cerebellum—multiple sclerosis	3.63e-05	0.0277	CbGeAlD
Azelastine—HRH3—GPCR downstream signaling—IL2—multiple sclerosis	3.56e-05	0.000376	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.55e-05	0.000375	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.55e-05	0.000375	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.52e-05	0.000371	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	3.51e-05	0.00037	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.5e-05	0.00037	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	3.49e-05	0.000369	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.48e-05	0.000367	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.48e-05	0.000367	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	3.47e-05	0.000366	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.47e-05	0.000366	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SPP1—multiple sclerosis	3.4e-05	0.000359	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	3.37e-05	0.000356	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	3.36e-05	0.000355	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	3.35e-05	0.000354	CbGpPWpGaD
Azelastine—ADRA1B—brain—multiple sclerosis	3.33e-05	0.0254	CbGeAlD
Azelastine—HRH3—Signaling Pathways—CCR5—multiple sclerosis	3.31e-05	0.000349	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.28e-05	0.000347	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.28e-05	0.000347	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.28e-05	0.000346	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL2RA—multiple sclerosis	3.26e-05	0.000344	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	3.26e-05	0.000344	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.25e-05	0.000343	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SRM—multiple sclerosis	3.24e-05	0.000342	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL2—multiple sclerosis	3.23e-05	0.000341	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	3.22e-05	0.00034	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.21e-05	0.000339	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	3.18e-05	0.000335	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	3.17e-05	0.000335	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	3.17e-05	0.000335	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	3.16e-05	0.000334	CbGpPWpGaD
Azelastine—KCNH2—medulla oblongata—multiple sclerosis	3.15e-05	0.024	CbGeAlD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	3.12e-05	0.000329	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	3.11e-05	0.000328	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	3.05e-05	0.000322	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	3.04e-05	0.000321	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	3.03e-05	0.00032	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—APOE—multiple sclerosis	3.01e-05	0.000318	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.01e-05	0.000317	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GPC5—multiple sclerosis	3e-05	0.000317	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	2.95e-05	0.000311	CbGpPWpGaD
Azelastine—CYP2A6—brain—multiple sclerosis	2.95e-05	0.0225	CbGeAlD
Azelastine—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.94e-05	0.00031	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.93e-05	0.00031	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.93e-05	0.00031	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	2.93e-05	0.000309	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	2.92e-05	0.000308	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	2.91e-05	0.000307	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	2.91e-05	0.000307	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	2.9e-05	0.000306	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.88e-05	0.000304	CbGpPWpGaD
Azelastine—KCNH2—midbrain—multiple sclerosis	2.88e-05	0.022	CbGeAlD
Azelastine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	2.88e-05	0.000304	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.87e-05	0.000303	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	2.87e-05	0.000303	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.87e-05	0.000303	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.86e-05	0.000302	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.86e-05	0.000302	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.82e-05	0.000298	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	2.82e-05	0.000297	CbGpPWpGaD
Azelastine—KCNH2—spinal cord—multiple sclerosis	2.81e-05	0.0214	CbGeAlD
Azelastine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	2.76e-05	0.000291	CbGpPWpGaD
Azelastine—CYP2D6—brainstem—multiple sclerosis	2.75e-05	0.021	CbGeAlD
Azelastine—HRH3—Signaling Pathways—CD80—multiple sclerosis	2.72e-05	0.000287	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.72e-05	0.000287	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.7e-05	0.000285	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.7e-05	0.000285	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.68e-05	0.000283	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.67e-05	0.000282	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.67e-05	0.000282	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	2.65e-05	0.00028	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	2.63e-05	0.000278	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	2.63e-05	0.000278	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	2.63e-05	0.000278	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.63e-05	0.000277	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.62e-05	0.000276	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.61e-05	0.000276	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—POMC—multiple sclerosis	2.58e-05	0.000273	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCL2—multiple sclerosis	2.53e-05	0.000267	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.5e-05	0.000264	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	2.5e-05	0.000264	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.49e-05	0.000263	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—MAPK1—multiple sclerosis	2.47e-05	0.000261	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.00026	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.45e-05	0.000258	CbGpPWpGaD
Azelastine—CYP2E1—medulla oblongata—multiple sclerosis	2.42e-05	0.0185	CbGeAlD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.4e-05	0.000253	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	2.38e-05	0.000252	CbGpPWpGaD
Azelastine—KCNH2—nervous system—multiple sclerosis	2.36e-05	0.0181	CbGeAlD
Azelastine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.32e-05	0.000245	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TYK2—multiple sclerosis	2.3e-05	0.000242	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.28e-05	0.000241	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.28e-05	0.000241	CbGpPWpGaD
Azelastine—KCNH2—central nervous system—multiple sclerosis	2.28e-05	0.0174	CbGeAlD
Azelastine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	2.27e-05	0.000239	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	2.26e-05	0.000239	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	2.25e-05	0.000238	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.23e-05	0.000236	CbGpPWpGaD
Azelastine—KCNH2—cerebellum—multiple sclerosis	2.23e-05	0.017	CbGeAlD
Azelastine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.22e-05	0.000235	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.22e-05	0.000234	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.17e-05	0.000229	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.17e-05	0.000229	CbGpPWpGaD
Azelastine—CYP2E1—spinal cord—multiple sclerosis	2.16e-05	0.0165	CbGeAlD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.11e-05	0.000222	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.09e-05	0.000221	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.09e-05	0.000221	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	2.07e-05	0.000219	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	2.05e-05	0.000217	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000216	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	2.04e-05	0.000216	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	2.04e-05	0.000215	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.03e-05	0.000214	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.01e-05	0.000213	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.01e-05	0.000212	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2e-05	0.000211	CbGpPWpGaD
Azelastine—CYP1A1—nervous system—multiple sclerosis	2e-05	0.0153	CbGeAlD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2e-05	0.000211	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	1.99e-05	0.00021	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	1.96e-05	0.000207	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.96e-05	0.000207	CbGpPWpGaD
Azelastine—CYP2B6—nervous system—multiple sclerosis	1.94e-05	0.0148	CbGeAlD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.93e-05	0.000204	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	1.93e-05	0.000203	CbGpPWpGaD
Azelastine—CYP1A1—central nervous system—multiple sclerosis	1.92e-05	0.0147	CbGeAlD
Azelastine—HRH3—Signaling Pathways—IL2—multiple sclerosis	1.91e-05	0.000202	CbGpPWpGaD
Azelastine—ABCB1—retina—multiple sclerosis	1.91e-05	0.0146	CbGeAlD
Azelastine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	1.91e-05	0.000201	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL6—multiple sclerosis	1.9e-05	0.000201	CbGpPWpGaD
Azelastine—HRH1—nervous system—multiple sclerosis	1.9e-05	0.0145	CbGeAlD
Azelastine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	1.87e-05	0.000198	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	1.87e-05	0.000198	CbGpPWpGaD
Azelastine—CYP2B6—central nervous system—multiple sclerosis	1.87e-05	0.0143	CbGeAlD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.86e-05	0.000197	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.85e-05	0.000195	CbGpPWpGaD
Azelastine—HRH1—central nervous system—multiple sclerosis	1.82e-05	0.0139	CbGeAlD
Azelastine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.82e-05	0.000192	CbGpPWpGaD
Azelastine—CYP2E1—nervous system—multiple sclerosis	1.82e-05	0.0139	CbGeAlD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.81e-05	0.000191	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MMP9—multiple sclerosis	1.81e-05	0.000191	CbGpPWpGaD
Azelastine—KCNH2—brain—multiple sclerosis	1.81e-05	0.0138	CbGeAlD
Azelastine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.8e-05	0.000191	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.78e-05	0.000188	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000186	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000186	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	1.76e-05	0.000186	CbGpPWpGaD
Azelastine—CYP2E1—central nervous system—multiple sclerosis	1.75e-05	0.0134	CbGeAlD
Azelastine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.74e-05	0.000184	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.73e-05	0.000183	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	1.73e-05	0.000182	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.73e-05	0.000182	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.72e-05	0.000182	CbGpPWpGaD
Azelastine—CYP2E1—cerebellum—multiple sclerosis	1.71e-05	0.0131	CbGeAlD
Azelastine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1.7e-05	0.000179	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.69e-05	0.000178	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.66e-05	0.000175	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000175	CbGpPWpGaD
Azelastine—CYP2C8—brain—multiple sclerosis	1.65e-05	0.0126	CbGeAlD
Azelastine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.00017	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—STAT3—multiple sclerosis	1.61e-05	0.00017	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.6e-05	0.000169	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.59e-05	0.000168	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.57e-05	0.000166	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.56e-05	0.000165	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.56e-05	0.000165	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.56e-05	0.000165	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.56e-05	0.000164	CbGpPWpGaD
Azelastine—CYP1A1—brain—multiple sclerosis	1.53e-05	0.0117	CbGeAlD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.51e-05	0.00016	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MYC—multiple sclerosis	1.49e-05	0.000158	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TGFB1—multiple sclerosis	1.49e-05	0.000157	CbGpPWpGaD
Azelastine—CYP2B6—brain—multiple sclerosis	1.48e-05	0.0113	CbGeAlD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.48e-05	0.000156	CbGpPWpGaD
Azelastine—CYP3A4—nervous system—multiple sclerosis	1.47e-05	0.0112	CbGeAlD
Azelastine—HRH3—Signaling Pathways—MAPK1—multiple sclerosis	1.46e-05	0.000154	CbGpPWpGaD
Azelastine—HRH1—brain—multiple sclerosis	1.45e-05	0.0111	CbGeAlD
Azelastine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.45e-05	0.000153	CbGpPWpGaD
Azelastine—CYP2D6—nervous system—multiple sclerosis	1.44e-05	0.011	CbGeAlD
Azelastine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000151	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.42e-05	0.00015	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.41e-05	0.000149	CbGpPWpGaD
Azelastine—CYP3A4—central nervous system—multiple sclerosis	1.41e-05	0.0108	CbGeAlD
Azelastine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.41e-05	0.000149	CbGpPWpGaD
Azelastine—CYP2E1—brain—multiple sclerosis	1.39e-05	0.0106	CbGeAlD
Azelastine—CYP2D6—central nervous system—multiple sclerosis	1.39e-05	0.0106	CbGeAlD
Azelastine—ABCB1—medulla oblongata—multiple sclerosis	1.38e-05	0.0105	CbGeAlD
Azelastine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.36e-05	0.000144	CbGpPWpGaD
Azelastine—CYP2D6—cerebellum—multiple sclerosis	1.36e-05	0.0104	CbGeAlD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.35e-05	0.000143	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.35e-05	0.000143	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.34e-05	0.000142	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.34e-05	0.000141	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.000141	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.3e-05	0.000137	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.28e-05	0.000136	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000135	CbGpPWpGaD
Azelastine—ABCB1—midbrain—multiple sclerosis	1.26e-05	0.00964	CbGeAlD
Azelastine—CYP2A6—Metabolism—APOE—multiple sclerosis	1.26e-05	0.000133	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.25e-05	0.000132	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.25e-05	0.000132	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.24e-05	0.000131	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.23e-05	0.00013	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.23e-05	0.00013	CbGpPWpGaD
Azelastine—ABCB1—spinal cord—multiple sclerosis	1.23e-05	0.0094	CbGeAlD
Azelastine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.21e-05	0.000128	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.21e-05	0.000127	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.19e-05	0.000126	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.18e-05	0.000125	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.18e-05	0.000124	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000124	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000123	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.15e-05	0.000122	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—multiple sclerosis	1.12e-05	0.000119	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.12e-05	0.000119	CbGpPWpGaD
Azelastine—CYP2D6—brain—multiple sclerosis	1.1e-05	0.00842	CbGeAlD
Azelastine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.1e-05	0.000116	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.09e-05	0.000115	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000114	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.08e-05	0.000114	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.07e-05	0.000113	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.05e-05	0.000111	CbGpPWpGaD
Azelastine—ABCB1—nervous system—multiple sclerosis	1.04e-05	0.00792	CbGeAlD
Azelastine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000107	CbGpPWpGaD
Azelastine—ABCB1—central nervous system—multiple sclerosis	9.99e-06	0.00763	CbGeAlD
Azelastine—CYP2E1—Metabolism—APOE—multiple sclerosis	9.95e-06	0.000105	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.94e-06	0.000105	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOE—multiple sclerosis	9.94e-06	0.000105	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOE—multiple sclerosis	9.93e-06	0.000105	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	9.93e-06	0.000105	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ALB—multiple sclerosis	9.86e-06	0.000104	CbGpPWpGaD
Azelastine—ABCB1—cerebellum—multiple sclerosis	9.76e-06	0.00745	CbGeAlD
Azelastine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	9.43e-06	9.96e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—multiple sclerosis	9.38e-06	9.91e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	9.23e-06	9.74e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	9.03e-06	9.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CD80—multiple sclerosis	8.99e-06	9.49e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—multiple sclerosis	8.73e-06	9.21e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—multiple sclerosis	8.6e-06	9.08e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—multiple sclerosis	8.55e-06	9.03e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—multiple sclerosis	8.54e-06	9.01e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—multiple sclerosis	8.53e-06	9.01e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	8.38e-06	8.85e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	8.35e-06	8.82e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.17e-06	8.63e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—multiple sclerosis	8.06e-06	8.51e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—multiple sclerosis	7.96e-06	8.4e-05	CbGpPWpGaD
Azelastine—ABCB1—brain—multiple sclerosis	7.93e-06	0.00606	CbGeAlD
Azelastine—CYP2E1—Metabolism—ALB—multiple sclerosis	7.79e-06	8.23e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—multiple sclerosis	7.78e-06	8.21e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—multiple sclerosis	7.68e-06	8.11e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.67e-06	8.1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	7.59e-06	8.01e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—multiple sclerosis	7.49e-06	7.91e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—multiple sclerosis	7.39e-06	7.8e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—multiple sclerosis	7.35e-06	7.76e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—multiple sclerosis	7.06e-06	7.46e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—multiple sclerosis	7e-06	7.39e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	6.97e-06	7.36e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	6.94e-06	7.33e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—multiple sclerosis	6.74e-06	7.11e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	6.6e-06	6.97e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.6e-06	6.96e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—multiple sclerosis	6.44e-06	6.8e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.31e-06	6.66e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.28e-06	6.63e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—multiple sclerosis	6.07e-06	6.4e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—multiple sclerosis	6.01e-06	6.35e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—multiple sclerosis	6.01e-06	6.35e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—multiple sclerosis	5.98e-06	6.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.97e-06	6.31e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—multiple sclerosis	5.87e-06	6.2e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	5.87e-06	6.19e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—multiple sclerosis	5.53e-06	5.84e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—multiple sclerosis	5.48e-06	5.79e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	5.45e-06	5.76e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	5.44e-06	5.74e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	5.33e-06	5.63e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.31e-06	5.61e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.14e-06	5.43e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.94e-06	5.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.92e-06	5.2e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.83e-06	5.1e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—multiple sclerosis	4.69e-06	4.95e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.62e-06	4.87e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.1e-06	4.33e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.97e-06	4.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.71e-06	3.92e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.62e-06	3.82e-05	CbGpPWpGaD
